"Metabolic Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
- Metabolic Diseases
- Diseases, Metabolic
- Disease, Metabolic
- Metabolic Disease
Below are MeSH descriptors whose meaning is more general than "Metabolic Diseases".
Below are MeSH descriptors whose meaning is more specific than "Metabolic Diseases".
This graph shows the total number of publications written about "Metabolic Diseases" by people in this website by year, and whether "Metabolic Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Metabolic Diseases" by people in Profiles.
Pleiotropy of systemic lupus erythematosus risk alleles and cardiometabolic disorders: A phenome-wide association study and inverse-variance weighted meta-analysis. Lupus. 2021 Jul; 30(8):1264-1272.
Regulation of Tissue Inflammation by 12-Lipoxygenases. Biomolecules. 2021 05 11; 11(5).
Race-Specific Comparisons of Antihypertensive and Metabolic Effects of Hydrochlorothiazide and Chlorthalidone. Am J Med. 2021 07; 134(7):918-925.e2.
The Gut Microbiome: Reaching the Promise Through Discovery- Advancing Knowledge and Discovery of the Gut Microbiome in the Age of Precision Medicine. Gastroenterology. 2021 01; 160(2):479-482.
Metabolic Dysfunction in Continuous-Flow Left Ventricular Assist Devices Patients and Outcomes. J Am Heart Assoc. 2019 11 19; 8(22):e013278.
Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa. Nat Genet. 2019 08; 51(8):1207-1214.
Developmental exposure to the endocrine disruptor tolylfluanid induces sex-specific later-life metabolic dysfunction. Reprod Toxicol. 2019 10; 89:74-82.
Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice. Mol Metab. 2019 07; 25:64-72.
Journal of Nutritional Biochemistry Special Issue: nutritional modulation of the gut microbiome in gastrointestinal and metabolic disease. J Nutr Biochem. 2019 04; 66:110-112.
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. Blood. 2019 02 14; 133(7):754-762.